Found "Digital Medicine": 186 results
Unpacking Digital Health: A breakdown of concepts and definitions
Digital health is an umbrella term that includes all healthcare services that are provided by ICT. From one’s personal wearable devices to the use of big data and AI in healthcare come under digital health’
Under the umbrella of digital health technology, various sub-groups such as electronic
English Policy Brief Collection – Volume 1
The English Policy Brief Collection (Volume 1) presents a selection of policy briefs published by the HITAP Foundation. These policy briefs have been categorized under the following key topics:
Chapter 1: Designing Universal Health Coverage (UHC) and Healthcare Systems
Chapter 2: Managing Rare
Value Distribution in New Branded Medicines: How Much Benefits Patients Versus Manufacturers?
Thailand has successfully implemented economic evaluation to inform the inclusion of new, branded medicines within its National List of Essential Medicines (NLEM). This method can be used to assess the health value that new medicines will generate for patients after accounting for the health los
Advanced health biotechnologies in Thailand: State of the art, future trends and strategic preparation
Aiming at appropriate preparation for the future development of individualized and regenerative medicine (in particular, gene, stem cell and tissue engineering therapies), the Health Intervention and Technology Assessment (HITAP) program has agreed to conduct a study to provide an insight on elements necessary for national policymaking in Thailand.
eSanjeevani, the National Telemedicine service: Bridging healthcare gaps in India
– eSanjeevani was developed primarily to tackle the challenges of inequitable healthcare access and the shortage of healthcare professionals in India
– The ‘one application’ approach ensured that only one application is used for the national telemedicine service delivery, thus ensuring interoper
Strategies for Sustainable Access: Unpacking Managed Entry Agreements (MEAs) and Innovative Medicine Access
MEAs aim at early access to high-cost innovative medicines at pre-determined terms that can ensure the financial sustainability of healthcare systems. However, their successful adoption hinges on a consideration of various factors to address the unique challenges faced by different nations.
The a
Radiation Concerns Rise With Patients’ Exposure
Even in health care systems in which doctors do not bill for each test they administer, the use of diagnostic imaging like CT and PET scans has soared, as has patients’ radiation exposure, a new study has found.The study, published online on Tuesday in The Journal of the American Medical Association
Sept. 11 Health Fund Given Clearance to Cover Cancer
A federal health official’s ruling has cleared the way for 50 different types of cancer to be added to the list of sicknesses covered by a $4.3 billion fund set up to compensate and treat people exposed to the toxic smoke, dust and fumes in the months after the Sept. 11, 2001, terrorist attacks.The
DNA Blueprint for Fetus Built Using Tests of Parents
For the first time, researchers have determined virtually the entire genome of a fetus using only a blood sample from the pregnant woman and a saliva specimen from the father.The accomplishment heralds an era in which parents might find it easier to know the complete DNA blueprint of a child months
The Trouble With ‘Doctor Knows Best’
Doctors were told last month that we should stop doing so many screenings for prostate cancer with the prostate-specific antigen test. We learned that sigmoidoscopy is a cheaper, easier and effective alternative to colonoscopy for colon cancer screening. And a study I led turned up strong evidence t
10 / Page